Selected research
Market Structure
Global Cardiovascular Health Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cardiovascular Health Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cardiovascular Health Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cardiovascular Health Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cardiovascular Health Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cardiovascular Health Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cardiovascular Health Supplements include Vital Nutrients, Thorne, Swisse, Somafina, NOW Foods, Nature's Way Products, Nature's Bounty, Metagenics and Kerry, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cardiovascular Health Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cardiovascular Health Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cardiovascular Health Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiovascular Health Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.
Cardiovascular Health Supplements Segment by Company
Vital Nutrients
Thorne
Swisse
Somafina
NOW Foods
Nature's Way Products
Nature's Bounty
Metagenics
Kerry
Herbalife International
GNC
DSM
BL Bio Lab
Bio-Tech Pharmacal
BioCare
BASF
Amway
Cardiovascular Health Supplements Segment by Type
Synthetic Supplements
Natural Supplements
Cardiovascular Health Supplements Segment by Application
Pharmacies and Hospitals
E-Commerce
Cardiovascular Health Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Health Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Health Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Health Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cardiovascular Health Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Health Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiovascular Health Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cardiovascular Health Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic Supplements
- Natural Supplements
Applications
- Pharmacies and Hospitals
- E-Commerce
Companies covered
- Vital Nutrients
- Thorne
- Swisse
- Somafina
- NOW Foods
- Nature's Way Products
- Nature's Bounty
- Metagenics
- Kerry
- Herbalife International
- GNC
- DSM
- BL Bio Lab
- Bio-Tech Pharmacal
- BioCare
- BASF
- Amway
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cardiovascular Health Supplements Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cardiovascular Health Supplements Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cardiovascular Health Supplements Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cardiovascular Health Supplements Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cardiovascular Health Supplements Market Dynamics
- 2.1 Cardiovascular Health Supplements Industry Trends
- 2.2 Cardiovascular Health Supplements Industry Drivers
- 2.3 Cardiovascular Health Supplements Industry Opportunities and Challenges
- 2.4 Cardiovascular Health Supplements Industry Restraints
3 Cardiovascular Health Supplements Market by Manufacturers
- 3.1 Global Cardiovascular Health Supplements Revenue by Manufacturers (2021-2026)
- 3.2 Global Cardiovascular Health Supplements Sales by Manufacturers (2021-2026)
- 3.3 Global Cardiovascular Health Supplements Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cardiovascular Health Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cardiovascular Health Supplements Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cardiovascular Health Supplements Manufacturers, Product Type & Application
- 3.7 Global Cardiovascular Health Supplements Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cardiovascular Health Supplements Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cardiovascular Health Supplements Players Market Share by Revenue in 2025
- 3.8.3 2025 Cardiovascular Health Supplements Tier 1, Tier 2, and Tier 3
4 Cardiovascular Health Supplements Market by Type
- 4.1 Cardiovascular Health Supplements Type Introduction
- 4.1.1 Synthetic Supplements
- 4.1.2 Natural Supplements
- 4.2 Global Cardiovascular Health Supplements Sales by Type
- 4.2.1 Global Cardiovascular Health Supplements Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cardiovascular Health Supplements Sales by Type (2021-2032)
- 4.2.3 Global Cardiovascular Health Supplements Sales Market Share by Type (2021-2032)
- 4.3 Global Cardiovascular Health Supplements Revenue by Type
- 4.3.1 Global Cardiovascular Health Supplements Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cardiovascular Health Supplements Revenue by Type (2021-2032)
- 4.3.3 Global Cardiovascular Health Supplements Revenue Market Share by Type (2021-2032)
5 Cardiovascular Health Supplements Market by Application
- 5.1 Cardiovascular Health Supplements Application Introduction
- 5.1.1 Pharmacies and Hospitals
- 5.1.2 E-Commerce
- 5.2 Global Cardiovascular Health Supplements Sales by Application
- 5.2.1 Global Cardiovascular Health Supplements Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cardiovascular Health Supplements Sales by Application (2021-2032)
- 5.2.3 Global Cardiovascular Health Supplements Sales Market Share by Application (2021-2032)
- 5.3 Global Cardiovascular Health Supplements Revenue by Application
- 5.3.1 Global Cardiovascular Health Supplements Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cardiovascular Health Supplements Revenue by Application (2021-2032)
- 5.3.3 Global Cardiovascular Health Supplements Revenue Market Share by Application (2021-2032)
6 Global Cardiovascular Health Supplements Sales by Region
- 6.1 Global Cardiovascular Health Supplements Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cardiovascular Health Supplements Sales by Region (2021-2032)
- 6.2.1 Global Cardiovascular Health Supplements Sales by Region (2021-2026)
- 6.2.2 Global Cardiovascular Health Supplements Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cardiovascular Health Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cardiovascular Health Supplements Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cardiovascular Health Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cardiovascular Health Supplements Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cardiovascular Health Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cardiovascular Health Supplements Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cardiovascular Health Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cardiovascular Health Supplements Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cardiovascular Health Supplements Revenue by Region
- 7.1 Global Cardiovascular Health Supplements Revenue by Region
- 7.1.1 Global Cardiovascular Health Supplements Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cardiovascular Health Supplements Revenue by Region (2021-2026)
- 7.1.3 Global Cardiovascular Health Supplements Revenue by Region (2027-2032)
- 7.1.4 Global Cardiovascular Health Supplements Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cardiovascular Health Supplements Revenue (2021-2032)
- 7.2.2 North America Cardiovascular Health Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cardiovascular Health Supplements Revenue (2021-2032)
- 7.3.2 Europe Cardiovascular Health Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cardiovascular Health Supplements Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cardiovascular Health Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cardiovascular Health Supplements Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cardiovascular Health Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Vital Nutrients
- 8.1.1 Vital Nutrients Company Information
- 8.1.2 Vital Nutrients Business Overview
- 8.1.3 Vital Nutrients Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Vital Nutrients Cardiovascular Health Supplements Product Portfolio
- 8.1.5 Vital Nutrients Recent Developments
- 8.2 Thorne
- 8.2.1 Thorne Company Information
- 8.2.2 Thorne Business Overview
- 8.2.3 Thorne Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thorne Cardiovascular Health Supplements Product Portfolio
- 8.2.5 Thorne Recent Developments
- 8.3 Swisse
- 8.3.1 Swisse Company Information
- 8.3.2 Swisse Business Overview
- 8.3.3 Swisse Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Swisse Cardiovascular Health Supplements Product Portfolio
- 8.3.5 Swisse Recent Developments
- 8.4 Somafina
- 8.4.1 Somafina Company Information
- 8.4.2 Somafina Business Overview
- 8.4.3 Somafina Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Somafina Cardiovascular Health Supplements Product Portfolio
- 8.4.5 Somafina Recent Developments
- 8.5 NOW Foods
- 8.5.1 NOW Foods Company Information
- 8.5.2 NOW Foods Business Overview
- 8.5.3 NOW Foods Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 NOW Foods Cardiovascular Health Supplements Product Portfolio
- 8.5.5 NOW Foods Recent Developments
- 8.6 Nature's Way Products
- 8.6.1 Nature's Way Products Company Information
- 8.6.2 Nature's Way Products Business Overview
- 8.6.3 Nature's Way Products Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Nature's Way Products Cardiovascular Health Supplements Product Portfolio
- 8.6.5 Nature's Way Products Recent Developments
- 8.7 Nature's Bounty
- 8.7.1 Nature's Bounty Company Information
- 8.7.2 Nature's Bounty Business Overview
- 8.7.3 Nature's Bounty Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nature's Bounty Cardiovascular Health Supplements Product Portfolio
- 8.7.5 Nature's Bounty Recent Developments
- 8.8 Metagenics
- 8.8.1 Metagenics Company Information
- 8.8.2 Metagenics Business Overview
- 8.8.3 Metagenics Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Metagenics Cardiovascular Health Supplements Product Portfolio
- 8.8.5 Metagenics Recent Developments
- 8.9 Kerry
- 8.9.1 Kerry Company Information
- 8.9.2 Kerry Business Overview
- 8.9.3 Kerry Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Kerry Cardiovascular Health Supplements Product Portfolio
- 8.9.5 Kerry Recent Developments
- 8.10 Herbalife International
- 8.10.1 Herbalife International Company Information
- 8.10.2 Herbalife International Business Overview
- 8.10.3 Herbalife International Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Herbalife International Cardiovascular Health Supplements Product Portfolio
- 8.10.5 Herbalife International Recent Developments
- 8.11 GNC
- 8.11.1 GNC Company Information
- 8.11.2 GNC Business Overview
- 8.11.3 GNC Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 GNC Cardiovascular Health Supplements Product Portfolio
- 8.11.5 GNC Recent Developments
- 8.12 DSM
- 8.12.1 DSM Company Information
- 8.12.2 DSM Business Overview
- 8.12.3 DSM Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 DSM Cardiovascular Health Supplements Product Portfolio
- 8.12.5 DSM Recent Developments
- 8.13 BL Bio Lab
- 8.13.1 BL Bio Lab Company Information
- 8.13.2 BL Bio Lab Business Overview
- 8.13.3 BL Bio Lab Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 BL Bio Lab Cardiovascular Health Supplements Product Portfolio
- 8.13.5 BL Bio Lab Recent Developments
- 8.14 Bio-Tech Pharmacal
- 8.14.1 Bio-Tech Pharmacal Company Information
- 8.14.2 Bio-Tech Pharmacal Business Overview
- 8.14.3 Bio-Tech Pharmacal Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Bio-Tech Pharmacal Cardiovascular Health Supplements Product Portfolio
- 8.14.5 Bio-Tech Pharmacal Recent Developments
- 8.15 BioCare
- 8.15.1 BioCare Company Information
- 8.15.2 BioCare Business Overview
- 8.15.3 BioCare Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 BioCare Cardiovascular Health Supplements Product Portfolio
- 8.15.5 BioCare Recent Developments
- 8.16 BASF
- 8.16.1 BASF Company Information
- 8.16.2 BASF Business Overview
- 8.16.3 BASF Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 BASF Cardiovascular Health Supplements Product Portfolio
- 8.16.5 BASF Recent Developments
- 8.17 Amway
- 8.17.1 Amway Company Information
- 8.17.2 Amway Business Overview
- 8.17.3 Amway Cardiovascular Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Amway Cardiovascular Health Supplements Product Portfolio
- 8.17.5 Amway Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cardiovascular Health Supplements Value Chain Analysis
- 9.1.1 Cardiovascular Health Supplements Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cardiovascular Health Supplements Production Mode & Process
- 9.2 Cardiovascular Health Supplements Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cardiovascular Health Supplements Distributors
- 9.2.3 Cardiovascular Health Supplements Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst